A Lunit é uma empresa de IA médica dedicada a vencer o cancro. Fornece soluções baseadas em IA para diagnóstico e terapêutica do cancro, ajudando os médicos a detetar o cancro em estágio inicial com maior precisão e a prever a resposta do paciente ao tratamento. Os seus produtos analisam imagens médicas e dados de tecidos para melhorar os resultados clínicos.
Uma plataforma de radiologia alimentada por IA, projetada para auxiliar profissionais médicos na análise de raios-X de tórax (CXR) e tomografias computadorizadas de pulmão. Aumenta a precisão e a eficiência do diagnóstico ao detectar automaticamente até 148 patologias, incluindo nódulos pulmonares e tuberculose, e integrando-se perfeitamente aos fluxos de trabalho clínicos existentes.
A Lunit é uma empresa de IA médica dedicada a vencer o cancro. Fornece soluções baseadas em IA para diagnóstico e terapêutica do cancro, ajudando os médicos a detetar o cancro em estágio inicial com maior precisão e a prever a resposta do paciente ao tratamento. Os seus produtos analisam imagens médicas e dados de tecidos para melhorar os resultados clínicos.
Uma plataforma de radiologia alimentada por IA, projetada para auxiliar profissionais médicos na análise de raios-X de tórax (CXR) e tomografias computadorizadas de pulmão. Aumenta a precisão e a eficiência do diagnóstico ao detectar automaticamente até 148 patologias, incluindo nódulos pulmonares e tuberculose, e integrando-se perfeitamente aos fluxos de trabalho clínicos existentes.
| Feature | Lunit | Rayscape |
|---|---|---|
| Categoria principal | Análise Preditiva | Diagnóstico |
| Adicionado | 2025-08-02 | 2025-08-07 |
| Preço | Não verificado | Não verificado |
| Site oficial | www.lunit.io | rayscape.ai |
| Tipo de produto | Site | Site |
| Performance data | ||
| Avaliação | Não verificado | Não verificado |
| Comentários | 0 | 0 |
| Visitas mensais | 38.4K | 6.5K |
| Crescimento mensal | -7.6% | -14.3% |
| Favoritos | 85 | 99 |
| Details | Ver detalhes | Ver detalhes |
Compare Lunit and Rayscape by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the Lunit vs Rayscape monthly traffic comparison, Lunit currently shows 38.4K visits and Rayscape shows 6.5K; Lunit has about 5.9 times the visible traffic of Rayscape, an absolute difference of about 31.8K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
Lunit is registered at the www.lunit.io/en subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 36.04% | 13.8K |
| 🇰🇷Korea, Republic of | 25.34% | 9.7K |
| 🇮🇳India | 16.94% | 6.5K |
| 🇻🇳Vietnam | 14.38% | 5.5K |
| 🇹🇷Turkey | 7.3% | 2.8K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direto | 92.51% | 35.5K |
| Referência | 5.74% | 2.2K |
| 1.75% | 671 |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 39.64% | 2.6K |
| 🇹🇷Turkey | 30.2% | 2K |
| 🇮🇳India | 30.16% | 2K |
This in-depth Lunit vs Rayscape comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Lunit is primarily listed under “Análise Preditiva”, while Rayscape is primarily listed under “Diagnóstico”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Lunit: Análise Preditiva; Rayscape: Diagnóstico); Monthly visits (Lunit: 38.4K; Rayscape: 6.5K); Monthly growth (Lunit: -7.6%; Rayscape: -14.3%); Favorites (Lunit: 85; Rayscape: 99); Website (Lunit: www.lunit.io; Rayscape: rayscape.ai). These facts are more useful for selection than brand visibility alone.
In the Lunit vs Rayscape monthly traffic comparison, Lunit currently shows 38.4K visits and Rayscape shows 6.5K; Lunit has about 5.9 times the visible traffic of Rayscape, an absolute difference of about 31.8K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
Lunit is registered at the www.lunit.io/en subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
Lunit is registered under a www.lunit.io subpath, so its large visible total may include the host platform. The current data does not justify choosing Lunit for traffic alone; shortlist by unique taxonomy and use case, then validate with the same tasks.
Lunit and Rayscape currently overlap in shared categories: Imagiologia Médica; shared tags: Diagnóstico de IA, IA na saúde, Imagiologia médica e Radiologia. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Lunit's unique categories/tags are Análise Preditiva, Oncologia, biomarcador, Detecção de câncer, Aprendizagem profunda, imunoterapia e oncologia; Rayscape's are Diagnóstico, Análise de Dados, Raio-X de tórax, Suporte à decisão clínica, TC pulmonar, detecção de nódulos pulmonares e Detecção de tuberculose. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
Lunit has no verified rating, 0 comments, 85 favorites, and 87 likes；Rayscape has no verified rating, 0 comments, 99 favorites, and 92 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put Lunit on the priority trial list when the task aligns with “Análise Preditiva” and especially Análise Preditiva, Oncologia, biomarcador, Detecção de câncer, Aprendizagem profunda e imunoterapia. This follows recorded positioning and does not imply unlisted capabilities are absent.
Lunit also currently records: pricing is not verified, product type is website, 38.4K monthly visits shown for the registered host (subpage scope unknown), no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Rayscape on the priority trial list when the task aligns with “Diagnóstico” and especially Diagnóstico, Análise de Dados, Raio-X de tórax, Suporte à decisão clínica, TC pulmonar e detecção de nódulos pulmonares. This follows recorded positioning and does not imply unlisted capabilities are absent.
Rayscape also currently records: pricing is not verified, product type is website, 6.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Lunit and Rayscape, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
